Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019
PLOS Medicine · 24.06.2025 · 22 (6) · e1004638
DOI: 10.1371/journal.pmed.1004638 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 24.06.2025. Verfasst von Gilbert Osena und 13 weiteren Autor:innen. Beteiligte Einrichtung: One Health Trust, Washington DC and Bengaluru, Bengaluru, India. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Anti-Bacterial Agents, Bacterial Infections. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Department of Health, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Antimicrobial resistance (AMR) is a major global health issue that exacerbates the burden of infectious diseases and healthcare costs. However, the scarcity of national-level AMR data in African countries hampers our understanding of its scale and contributing factors in the region. To gain insights into AMR prevalence in Africa, we collected and analyzed retrospective AMR data from 14 countries. Methods and findings We estimated bacterial AMR prevalence, defined as the proportion of resistant human isolates tested from antimicrobial susceptibility (AST) data collected retrospectively for 2016–2019 from 205 laboratories across 14 African countries. We generated 95% confidence intervals (CIs) for aggregated AMR estimates to account for data quality disparities across countries; the median data quality score was 73.1%, ranging from 56.4% to 80.8%. We assessed 819,584 culture records covering 9,266 pathogen–drug combinations, of which 187,832 (22.9%) were positive cultures with AST results. The most frequently cultured specimens were urine (32.0%) and purulent samples (28.1%), and the most frequently isolated pathogens were Escherichia coli (22.2%) and Staphylococcus aureus (15.0%). Aggregated AMR estimates did not change significantly across the years studied ( p > 0.337); however, there were significant variations in AMR prevalence estimates in culture-positive samples across countries, regions, patient departments (inpatient/outpatient), and specimen sources ( p < 0.05). Male sex (adjusted odds ratio [aOR] 1.15; 95% CI [1.09,1.21]; p < 0.0001), ages above 65 (aOR 1.28; 95% CI [1.16–1.41]; p < 0.0001), and inpatient department (aOR 1.24; 95% CI [1.13–1.35]; p < 0.0001) were associated with higher AMR prevalence among culture-positive samples. The lack of routine testing, as reflected in the low data volume from most contributing laboratories, and the absence of patient clinical information, represent significant limitations of this study.
Conclusion
Analysis of the largest retrospective AMR dataset in Africa indicates high variability in AMR prevalence across countries, coupled with differences in AMR testing capacities, data quality, and AMR estimates. Gaps in AST practices and inadequate digital infrastructures for data collection and reporting represent barriers to estimating the true AMR burden in the region. These barriers warrant large-scale investments to expand healthcare access and strengthen bacteriology laboratory capacities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- One Health Trust, Washington DC and Bengaluru, Bengaluru, India.
- Department of Infectious Diseases, Institute for Biomedicine, University of Gothenburg, Gothenburg, Sweden.
- African Society for Laboratory Medicine, Addis Ababa, Ethiopia.
- Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.
- Innovative Support to Emergencies, Diseases and Disasters (InSTEDD), Seattle, Washington, United States of America.
- East, Central and Southern African Health Community, Arusha, Tanzania.
ORCID-Profile: Erta Kalanxhi, Timothée Ouassa, Edwin Shumba, Sehr Brar, Yewande Alimi, Manuel Moreira, Eili Klein, Pascale Ondoa, Ramanan Laxminarayan
Förderung
- UK Department of Health
- Centers for Disease Control and Prevention
Zitieren
APA
Osena, G., Kapoor, G., Kalanxhi, E., Ouassa, T., Shumba, E., Brar, S., Alimi, Y., Moreira, M., Matu, M., Sow, A., Klein, E., Ondoa, P., Laxminarayan, R., & MAAP Study Group (2025). Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019. PLOS Medicine, 22(6), e1004638. https://doi.org/10.1371/journal.pmed.1004638
Vancouver
Osena G, Kapoor G, Kalanxhi E, Ouassa T, Shumba E, Brar S, et al. Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019. PLOS Medicine. 2025;22(6):e1004638. doi:10.1371/journal.pmed.1004638
BibTeX
@article{Osena2025,
author = {Osena, Gilbert and Kapoor, Geetanjali and Kalanxhi, Erta and Ouassa, Timothée and Shumba, Edwin and Brar, Sehr and Alimi, Yewande and Moreira, Manuel and Matu, Martin and Sow, Abdourahmane and Klein, Eili and Ondoa, Pascale and Laxminarayan, Ramanan and MAAP Study Group, MAAP Study Group},
title = {Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019},
journal = {PLOS Medicine},
year = {2025},
volume = {22},
number = {6},
pages = {e1004638},
doi = {10.1371/journal.pmed.1004638}
}
EUVIMED